Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle

FRANGULA ALNUS BARK.

Avoid CAS 84625-48-9 / SKIN CONDITIONING

Frangula Alnus Bark, sourced from the alder buckthorn tree, naturally contains anthranoid compounds like frangulin. Historically, its fresh bark necessitates specific aging or heat treatment to mitigate inherent irritating and emetic properties before use.

Antioxidant Antibacterial Antifungal Antiviral

Science

The mechanism of Frangula Alnus Bark involves its anthranoid compounds, such as frangulin, which contribute to its observed antioxidant, antibacterial, fungicidal, and antiviral activities. Extracts may also modulate bacterial membrane permeability, potentially disrupting microbial integrity.


Research

Low confidence
Effective range N/A
Optimal

N/A


Transparency

Not commonly dusted

Due to significant safety concerns regarding potential irritation and cellular damage, this ingredient is unlikely to be 'dusted' at sub-efficacious concentrations. The primary challenge lies in establishing a safe and effective concentration range for topical cosmetic applications, which remains largely undefined.


The Formula

Solubility
Both
Optimal pH N/A
0 7 14

Stability

Extracts demonstrate moderate solubility in distilled water and enhanced solubility in more polar alcoholic solutions like ethanol. Frangulin, a key constituent, is soluble in alkaline solutions. The ingredient's natural color exhibits pH sensitivity, presenting as golden yellows in acidic conditions and shifting to brick reds at alkaline pH values between 10-11.


Safety

CIR Status
Not reviewed
Sensitization risk High

Frangula Alnus Bark is currently listed on the Cosmetic Ingredient Review (CIR) 2023 and 2024 Draft Priority Lists for forthcoming assessment. There is no specific SCCS opinion or FDA status for its topical cosmetic use. Fresh bark is known to be irritating and emetic, thus requiring aging for approximately one year or heat treatment prior to use to reduce irritating anthrones. A study on human peripheral blood lymphocytes indicated that a bark extract concentration of 500 µg/ml induced cell death and DNA damage. Furthermore, emodin, a component, increased reactive oxygen species (ROS) at 25 µg/ml, suggesting potential cyto/genotoxicity at certain concentrations and advising significant caution. The European Medicines Agency (EMA) recognizes Frangula Alnus bark as a traditional herbal medicinal product for short-term use in cases of constipation, which pertains to internal, not topical, application.


Your Skin

No Normal
No Dry
No Oily
No Sensitive
Irritancy High
Comedogenicity Unknown

Our Assessment

Avoid

Given the substantial unaddressed safety concerns, including documented potential for irritation, cell death, and DNA damage at specific concentrations, coupled with a lack of clear clinical efficacy data for topical skin benefits, this ingredient is not recommended for precision skincare formulations.


Related

Finding similar ingredients…